company

SKANDINAVISK REVMATOLOGISK FORSKNING

0370 OSLO

Return on Equity
−7,75 %
Current Ratio
34,3
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 668 000
Net Income−991 000
Total Assets13 171 000
Total Equity12 787 000
Income (NOK)2022
Revenue1 668 000
Expenditure1 727 000
Operating Profit−59 000
Financial Income138 000
Financial Costs1 071 000
Financial Balance−933 000
Earnings Before Tax−991 000
Tax0
Net Income−991 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets13 171 000
Total Assets13 171 000
Total Retained Equity12 587 000
Total Equity12 787 000
Total Long-Term Debt0
Total Current Debt384 000
Total Equity and Debt13 171 000
Cash flow (NOK)2022
Sales Income1 668 000
Other Income0
Revenue1 668 000
Cost of Goods Sold7 000
Salary Costs179 000
Depreciation0
Impairment0
Expenditure1 727 000
Operating Profit−59 000
Financial Income138 000
Financial Costs1 071 000
Financial Balance−933 000
Dividends0
Net Income−991 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments10 189 000
Cash, Bank1 753 000
Total Current Assets13 171 000
Total Assets13 171 000
Total Equity12 787 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors240 000
Unpaid Taxes31 000
Dividends0
Other Current Debt113 000
Total Current Debt384 000
Total Equity and Debt13 171 000
Financial indicators2022
Return on Equity−7,75 %
Debt-to-Equity Ratio0
Operating Profit Margin−3,54 %
Current Ratio34,3
Quick Ratio34,3
Equity Ratio0,97
Gross Profit Margin99,58 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English